微生物群
结直肠癌
生酮饮食
免疫系统
生物
癌症研究
硬脂酸盐
肠道菌群
癌症
益生元
肠道微生物群
内分泌学
内科学
免疫学
医学
化学
生物化学
生物信息学
癫痫
有机化学
神经科学
作者
Mina Tsenkova,Madita Brauer,Vitaly I. Pozdeev,Marat F. Kasakin,Susheel Bhanu Busi,Maryse Schmoetten,Dean Cheung,Marianne Meyers,Fabien Rodriguez,Anthoula Gaigneaux,Eric Koncina,Cedric Gilson,Lisa Schlicker,Diran Herebıan,Martine Schmitz,Laura de Nies,Ertan Mayatepek,Serge Haan,Carine de Beaufort,Thorsten Cramer
标识
DOI:10.1038/s41467-025-56678-0
摘要
Colorectal cancer (CRC) patients have been shown to possess an altered gut microbiome. Diet is a well-established modulator of the microbiome, and thus, dietary interventions might have a beneficial effect on CRC. An attenuating effect of the ketogenic diet (KD) on CRC cell growth has been previously observed, however the role of the gut microbiome in driving this effect remains unknown. Here, we describe a reduced colonic tumor burden upon KD consumption in a CRC mouse model with a humanized microbiome. Importantly, we demonstrate a causal relationship through microbiome transplantation into germ-free mice, whereby alterations in the gut microbiota were maintained in the absence of continued selective pressure from the KD. Specifically, we identify a shift toward bacterial species that produce stearic acid in ketogenic conditions, whereas consumers were depleted, resulting in elevated levels of free stearate in the gut lumen. This microbial product demonstrates tumor-suppressing properties by inducing apoptosis in cancer cells and decreasing colonic Th17 immune cell populations. Taken together, the beneficial effects of the KD are mediated through alterations in the gut microbiome, including, among others, increased stearic acid production, which in turn significantly reduces intestinal tumor growth.
科研通智能强力驱动
Strongly Powered by AbleSci AI